EMEA-000969-PIP01-10-M04

Key facts

Invented name
Tybost
Active substance
cobicistat
Therapeutic area
Infectious diseases
Decision number
P/0060/2017
PIP number
EMEA-000969-PIP01-10-M04
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate tablet
  • Age-appropriate dispersible tablet
Condition(s) / indication(s)
Treatment of human-immunodeficiency-virus type-1 (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Gilead Sciences International Limited

Tel. +44 (0)1223 897 300
E-mail: regulatory.pip@gilead.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating